Ten-year follow-up of sitagliptin treatment in patients with type 2 diabetes mellitus

BACKGROUND: Early and effective intervention with a dipeptidyl peptidase 4 inhibitor (DPP4i) before the development of advanced atherosclerosis in type 2 diabetes mellitus (T2DM) patients without a history of cardiovascular disease (CVD) is reported to increase the chance of significant reductions i...

Descripción completa

Detalles Bibliográficos
Autor principal: Hattori, Sachiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542356/
https://www.ncbi.nlm.nih.gov/pubmed/34689790
http://dx.doi.org/10.1186/s13098-021-00735-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542356/
https://www.ncbi.nlm.nih.gov/pubmed/34689790
http://dx.doi.org/10.1186/s13098-021-00735-3

Ejemplares similares